Clinical Characteristics and Antibiotic Resistance of Mycoplasma Pneumoniae Pneumonia in Hospitalized Chinese Children

Author(s): Chen Yuan, Fang-Mei Min, Yin-Jie Ling, Gang Li, Hong-Zhou Ye, Jia-Hui Pan, Ling Wang, Yan-Ping Xie*.

Journal Name: Combinatorial Chemistry & High Throughput Screening

Volume 21 , Issue 10 , 2018

Become EABM
Become Reviewer

Abstract:

Aim: To analyze the clinical characteristics and antibiotic resistance of Mycoplasma pneumoniae pneumonia (MP) in Chinese patients, providing valuable information for the management of patients with MP.

Methods: A total of 120 children who were hospitalized in The First Hospital of Huzhou between January and December 2016 for respiratory tract infection due to M. pneumoniae were enrolled in this study. Infection with M. pneumoniae was confirmed by ELISA for M. pneumoniae antibody, PCR, and throat culture. Antibiotic resistance was measured from the minimum inhibitory concentrations (MICs) of antibiotics. The 23S rRNA gene of M. pneumoniae was also examined for mutations using DNA sequencing. Patients with MP were classified into antibiotic resistance (n = 98) and no resistance (n = 20) groups. For the 98 patients showing antibiotic resistance, they were further stratified into subgroups based on the antibiotics initially prescribed: azithromycin or erythromycin (n = 78) and cephalosporin or penicillin (n = 20). Clinical characteristics were compared between the patient groups.

Results: Antibiotic resistance group presented significantly longer febrile days compared to the no resistance group (P = 0.007). The number of febrile days after macrolide treatment was also longer in antibiotic resistance group than in no resistance group (P = 0.042). MP patients initially treated with azithromycin or erythromycin showed a longer average duration of respiratory symptoms (P = 0.046) and had a fever for more days after macrolide treatment (P = 0.009) compared to those received cephalosporin or penicillin. The average white blood cell count of patients treated with azithromycin or erythromycin was nearly half of those treated with cephalosporin or penicillin (P < 0.001). Nearly 90% of the resistant M. pneumoniae strains showed A to G substitution at position 2063 of the 23S rRNA gene.

Conclusion: The clinical characteristics and antibiotic resistance of MP were analyzed in 120 Chinese patients. DNA sequencing revealed a highly prevalent A2063G mutation in the 23S rRNA gene.

Keywords: Mycoplasma pneumoniae, pneumonia, antibiotic resistance, macrolide, macrolide-resistant, pathogens.

[1]
Waites, K.B.; Xiao, L.; Liu, Y.; Balish, M.F.; Atkinson, T.P. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin. Microbiol. Rev., 2017, 30, 747-809.
[2]
Bradley, J.S.; Byington, C.L.; Shah, S.S.; Alverson, B.; Carter, E.R.; Harrison, C.; Kaplan, S.L.; Mace, S.E.; McCracken, G.H. Jr.; Moore, M.R.; St Peter, S.D.; Stockwell, J.A.; Swanson, J.T.; Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin. Infect. Dis., 2011, 53, 617-630.
[3]
de Groot, R.C.A.; Meyer Sauteur, P.M.; Unger, W.W.J.; van Rossum, A.M.C. Things that could be Mycoplasma pneumoniae. J. Infect., 2017, 74(Suppl. 1), S95-S100.
[4]
Yamada, M.; Buller, R.; Bledsoe, S.; Storch, G.A. Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States. Pediatr. Infect. Dis., 2012, 31(4), 409-410.
[5]
Peuchant, O.; Menard, A.; Renaudin, H.; Morozumi, M.; Ubukata, K.; Bébéar, C.M.; Pereyre, S. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J. Antimicrob. Chemother., 2009, 64, 52-58.
[6]
Dumke, R.; von Baum, H.; Luck, P.C.; Jacobs, E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin. Microbiol. Infect., 2010, 16, 613-616.
[7]
Okada, T.; Morozumi, M.; Tajima, T.; Hasegawa, M.; Sakata, H.; Ohnari, S.; Chiba, N.; Iwata, S.; Ubukata, K. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin. Infect. Dis., 2012, 55, 1642-1649.
[8]
Cao, B.; Zhao, C.J.; Yin, Y.D.; Zhao, F.; Song, S.F.; Bai, L.; Zhang, J.Z.; Liu, Y.M.; Zhang, Y.Y.; Wang, H.; Wang, C. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin. Infect. Dis., 2010, 51, 189-194.
[9]
Matsuoka, M.; Narita, M.; Okazaki, N.; Ohya, H.; Yamazaki, T.; Ouchi, K.; Suzuki, I.; Andoh, T.; Kenri, T.; Sasaki, Y.; Horino, A.; Shintani, M.; Arakawa, Y.; Sasaki, T. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob. Agents Chemother., 2004, 48, 4624-4630.
[10]
Lucier, T.S.; Heitzman, K.; Liu, S.K.; Hu, P.C. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob. Agents Chemother., 1995, 39, 2770-2773.
[11]
Diaz, M.; Benitez, A.; Cross, K.; Hicks, L.; Kutty, P.; Bramley, A.M.; Chappell, J.D.; Hymas, W.; Patel, A.; Qi, C.; Williams, D.J.; Arnold, S.R.; Ampofo, K.; Self, W.H.; Grijalva, C.G.; Anderson, E.J.; McCullers, J.A.; Pavia, A.T.; Wunderink, R.G.; Edwards, K.M.; Jain, S.; Winchell, J.M. Molecular detection and characterization of M. pneumoniae among patients hospitalized with community-acquired pneumonia in the United States Open Forum. Infect. Dis, 2015, 2, ofv106.
[12]
Wistler, T.; Sawatwong, P.; Diaz, M.; Benitez, A.; Wolff, B.J.; Sapchookul, P.; Thamthitiwat, S.; Winchell, J.M. Molecular characterization of Mycoplasma pnuemoniae infections in two rural populations of Thailand from 2009 to 2012. J. Clin. Microbiol., 2017, 55, 2222-2233.
[13]
Deng, H.; Rui, J.; Zhao, D.; Liu, F. Mycoplasma pneumoniae 23S rRNA A2063G mutation does not influence c; chest radiography features in children with pneumonia. J. Int. Med. Res., 2018, 46, 150-157.
[14]
Razin, S.; Yogev, D.; Naot, Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol. Mol. Biol. Rev., 1998, 62, 1094-1156.
[15]
Sun, H.; Xue, G.; Yan, C.; Li, S.; Zhao, H.; Feng, Y.; Wang, L. Changes in molecular characteristics of Mycoplasma pneumoniae in clinical specimens from children in Beijing between 2003 and 2015. PLoS One, 2017, 12, e0170253.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 10
Year: 2018
Page: [749 - 754]
Pages: 6
DOI: 10.2174/1386207322666190111112946
Price: $58

Article Metrics

PDF: 37
HTML: 3